Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy Neuzillet

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
The Lancet. Gastroenterology & Hepatology|August 6, 2021
Infigratinib in pretreated cholangiocarcinoma with FGFR2 fusions or rearrangementsCindy Neuzillet
The Lancet. Gastroenterology & Hepatology|March 12, 2022
First-line chemotherapy plus immunotherapy in biliary tract cancerCindy Neuzillet
The Lancet. Oncology|September 13, 2025
Neoadjuvant approaches in non-metastatic pancreatic cancer: where do we stand?Matthieu Delaye, Cindy Neuzillet
Bulletin Du Cancer|September 18, 2020
[New drug approval: Olaparib - pancreatic cancer with BRCA germline mutation]Marc Hilmi, Cindy Neuzillet
Bulletin Du Cancer|August 19, 2022
[New drug approval: Nivolumab plus Ipilimumab/chemotherapy in esophageal squamous-cell carcinoma]Céline Chalah, Cindy Neuzillet
Translational Cancer Research|February 4, 2022
Cholangiocarcinoma: the quest for a second-line systemic treatmentAngélique Vienot, Cindy Neuzillet
Clinics and Research in Hepatology and Gastroenterology|June 27, 2020
Continuum of care for advanced biliary tract cancersAngélique Vienot, Cindy Neuzillet
Presse Medicale (Paris, France : 1983)|March 18, 2019
Pancreatic cancer: Best supportive careAnne-Laure Védie, Cindy Neuzillet
Bulletin Du Cancer|July 22, 2018
[Maintenance strategies for advanced pancreatic cancer: Rationale and issues]Anthony Turpin, Hortense Chevalier, Cindy Neuzillet
Bulletin Du Cancer|December 19, 2022
Matthieu Delaye, Astrid Lièvre, Cindy Neuzillet
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
The Lancet. Gastroenterology & Hepatology|August 6, 2021
Infigratinib in pretreated cholangiocarcinoma with FGFR2 fusions or rearrangementsCindy Neuzillet
The Lancet. Gastroenterology & Hepatology|March 12, 2022
First-line chemotherapy plus immunotherapy in biliary tract cancerCindy Neuzillet
The Lancet. Oncology|September 13, 2025
Neoadjuvant approaches in non-metastatic pancreatic cancer: where do we stand?Matthieu Delaye, Cindy Neuzillet
Bulletin Du Cancer|September 18, 2020
[New drug approval: Olaparib - pancreatic cancer with BRCA germline mutation]Marc Hilmi, Cindy Neuzillet
Bulletin Du Cancer|August 19, 2022
[New drug approval: Nivolumab plus Ipilimumab/chemotherapy in esophageal squamous-cell carcinoma]Céline Chalah, Cindy Neuzillet
Translational Cancer Research|February 4, 2022
Cholangiocarcinoma: the quest for a second-line systemic treatmentAngélique Vienot, Cindy Neuzillet
Clinics and Research in Hepatology and Gastroenterology|June 27, 2020
Continuum of care for advanced biliary tract cancersAngélique Vienot, Cindy Neuzillet
Presse Medicale (Paris, France : 1983)|March 18, 2019
Pancreatic cancer: Best supportive careAnne-Laure Védie, Cindy Neuzillet
Bulletin Du Cancer|July 22, 2018
[Maintenance strategies for advanced pancreatic cancer: Rationale and issues]Anthony Turpin, Hortense Chevalier, Cindy Neuzillet
Bulletin Du Cancer|December 19, 2022
Matthieu Delaye, Astrid Lièvre, Cindy Neuzillet
Pageof 14